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•	 	Coronary artery disease and its extreme manifestation - ST-Elevation Myocardial Infarction - remains 
among the leading cause of death in the United States. Significant research has been devoted to 
reducing the morbidity and mortality of this condition. Early reperfusion has been established as an 
important consideration in improving outcomes.
•	 	As such, in 2007 the American College of Cardiology and American Heart Association set a goal of 
reperfusion of the infarct artery to within 90 minutes of presentation. This benchmark was shown as a 
cutoff time beyond which significantly worsened outcomes could be expected, and became known as 
“door to balloon time.”
•	 	In addition to mortality, major adverse cardiac events are also 
reduced with improvements in door to balloon time. However, 
fewer studies have examined the relationship between door to 
balloon time and in-hospital complications.
•	 	At Lehigh Valley Health Network, we have established a protocol 
for rapid transfer to the cardiac catheterization laboratory 
that can be initiated by ED, Cardiology or EMS. The ‘MI Alert’ 
pathway standardizes medications and therapies and has 
helped reduce door to balloon time. (Figure 1)
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Figure 1. MI Alert Protocol 
Objective
•	 	Our study examined the relationship between door to balloon time and time to hospital discharge. We 
believe that time to hospital discharge is an effective surrogate for measuring in-hospital complications. 
The hypothesis is that time to hospital discharge would be reduced as door to balloon time is 
improved.
Methods
•	 	We examined 77 patients presenting to Lehigh Valley Health Network from 2008-2011 with Acute 
ST-Elevation Myocardial Infarction, as determined by activation of the ‘MI Alert’ pathway who were 
deemed to be acceptable candidates for emergency cardiac catheterization and percutaneous 
intervention. 
•	 	Of these 77 patients, 40 (52%) had a door to balloon time of less than 30 minutes (referred to as the 
“early” cohort) and 37 (49%) of which had a door to balloon time of > 90 minutes (“late” cohort).
•	 	Eight patients were excluded from the final analysis in the late cohort (termed “late cohort with 
exclusions”) Of these eight patients, six were excluded for presence of cardiogenic shock, one for 
preexisting multiorgan failure and one for ventricular fibrillation arrest requiring hypothermic cooling. No 
patients were excluded from the early group.
•	 	Door to balloon time of the cohorts is presented below. (Table 1)
•	 	Demographic data such as age, as well as coronary artery disease risk factors such as male gender, 
hypertension, tobacco use, history of coronary artery disease, diabetes, dyslipidemia, prior CVA and 
age were similar between the two groups (Table 2). (p-values represent difference between early 
cohort and late cohort with exclusions).
Results
•	 	Overall mean time to hospital discharge in the early group 
was 3.33 days whereas it lengthened to 5.02 days in the late 
group with exclusions (p = 0.011). Without exclusions the 
mean time to hospital discharge was 6.83 days.  (Graph 1)
•	 	Five deaths were noted (4 from cardiac etiologies) in the late 
group. No deaths were seen in the early group.
•	 	In the late group, six patients were diagnosed with 
cardiogenic shock compared with one in the early group.
•	 	Left ventricular ejection fraction is significantly lower in the 
late groups. The prevalence of anterior myocardial infarction 
trended higher in the late groups. (Table 3)
•	 	Even after excluding patients in cardiogenic shock, a clear 
difference is still noted in time to hospital discharge as it 
relates to door to balloon time.
Conclusions
•	 	Reducing door to balloon time meaningfully reduces hospital stay.
•	 	Short door to balloon times were associated with fewer mortalities and episodes of cardiogenic shock.
•	 	A hypothesis for this difference could include salvage of more myocardial muscle by faster 
revascularization, as demonstrated by a statistically higher left ventricular ejection fraction in those 
revascularized early.
•	 	Confounding factors include increased prevalence of anterior myocardial infarction in the late cohort.
•	 	Future direction involves quantifying scar burden by follow-up echocardiogram or MRI as well as 
examining outcomes at 30 days and 1 year.








Door to Balloon (min) 24.9 +/- 4.7 134.8 +/- 61.2 128.7 +/- 48.0  
Table 2.  Demographic Data and Risk Factors







Average age (yrs) 61.3 +/- 9.9 65.9 +/- 13.1 64.1 +/- 13.8 0.365
Male Gender 72.5% 76.3% 81.8% 0.314
Hypertension 72.5% 63.2% 50.0% 0.545
Tobacco Use 25.0% 28.9% 26.3% 0.407
Prior CAD 25.0% 34.2% 21.1% 0.814
Diabetes 25.0% 36.8% 31.6% 0.164
Dyslipidemia 77.5% 65.8% 55.3% 0.639
Prior CVA 2.5% 15.8% 10.5% 0.114
Combined 2.275 2.38 2.55 0.309








Left Ventricular Ejection 
Fraction (EF%) 50.8 +/- 8.8 39.1 +/- 11.2 40.7 +/- 11.0 <0.001
Drug Eluting Stent 52.5% 45.9% 51.7% 0.950
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